# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.482625998316275	Range of duration = 0.2 to 204.62, nDeath = 16, nCensor = 9
2	AGE	t-test	0.673424317007974	Range of values = 43 to 85, Mean = 66.28, StdDev = 14.2815
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.745992081802633	nTypes = 3 (DISTANT METASTASIS/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 7/5/13
4	GENDER	Fisher's exact test	0.0875390056168089	nTypes = 2 (FEMALE/MALE), nPatients = 8/17
5	LYMPH.NODE.METASTASIS	Chi-square test	0.666073868263858	nTypes = 4 (N0/N1B/N2C/N3), nPatients = 16/3/2/2, nMissing = 2
6	TUMOR.STAGECODE	t-test	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 25
7	NEOPLASM.DISEASESTAGE	Chi-square test	0.576884547946406	nTypes = 7 (STAGE IA/STAGE IB/STAGE II/STAGE IIB/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 3/1/6/3/3/4/1, nMissing = 4